Example: Heart Attack

Search clinical trials for: Purinergic P2 Receptor Antagonists

Total 798 results

NCT04501900

Not yet recruiting

The 3 Years vs 1 Year DAPT After XINSORB BRS Implantation

Conditions: Cardiovascular Diseases
NCT04502017

Recruiting

Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion

Conditions: Device-Related Thrombosis; Atrial Fibrillation; Left Atrial Appendage Occlusion
NCT04483583

Not yet recruiting

Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI

Conditions: Coronary Artery Disease
NCT04484259

Not yet recruiting

Ticagrelor With and Without Aspirin in Patients With Diabetes Mellitus

Conditions: Diabetes Mellitus, Type 2; Coronary Artery Disease
NCT04442919

Recruiting

Influence of METHoxyflurane on ANtiplatelet Effect of Ticagrelor in Patients With Unstable Angina Pectoris

Conditions: Unstable Angina
NCT04431349

Completed

Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel

Conditions: Blood Loss, Surgical; Ticagrelor; Clopidogrel
NCT04434365

Active, not recruiting

Effect of Berberine for Endothelial Function and Intestinal Microflora in Patients With Coronary Artery Disease

Conditions: Stable Coronary Artery Disease; Percutaneous Coronary Intervention
NCT04420351

Not yet recruiting

Thrombolysis of Urokinase for Minor Stroke

Conditions: Minor Stroke
NCT04418479

Not yet recruiting

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3

Conditions: Coronary Artery Disease
NCT04409834

Not yet recruiting

Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial

Conditions: COVID-19; Venous Thromboembolism; Arterial Thrombosis
NCT04407312

Active, not recruiting

Cilostazol and Endothelial Progenitor Cell

Conditions: Myocardial Infarction, Acute
NCT04393025

Completed

Endovascular Stenting of Medically Refractory ICASD (Clinical and Sonographic Study)

Conditions: Stroke, Ischemic
NCT04369534

Completed

Efficacy and Safety of Individualized P2Y12 Receptor Antagonists Treatment Based on Agregometry Versus Fixed Dose Regimen in Patients After Acute Myocardial Infarction

Conditions: Acute Coronary Syndrome; STEMI; NSTEMI - Non-ST Segment Elevation MI; PLATELET AGGREGATION; INDIVIDUALIZED THERAPY
NCT04368377

Completed

Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19

Conditions: Pneumonia, Viral; Corona Virus Infection; Respiratory Failure; Embolism and Thrombosis
NCT04338919

Recruiting

Optimized Antiplatelet Therapy on the Prognosis of ACS Patients With Non-predominant Coronary Artery Disease After PCI

Conditions: Acute Coronary Syndrome; Percutaneous Coronary Intervention
NCT04333407

Recruiting

Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

Conditions: COVID-19
NCT04331145

Recruiting

Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation

Conditions: Symptomatic Aortic Stenosis
NCT04307485

Recruiting

A Study of Low Dose vs Standard Ticagrelor on Platelet Function After Intervention for Acute Coronary Syndrome in Senior Patients

Conditions: Senior Acute Coronary Syndrome Patients After PCI
NCT04307511

Recruiting

A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients

Conditions: Acute Coronary Syndrome Patients With Diabetes After PCI
NCT04305587

Recruiting

Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

Conditions: Diabetes Mellitus Type 2
NCT04293172

Withdrawn

Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.

Conditions: Sickle Cell Disease
NCT04267224

Not yet recruiting

Early Versus Late Loading of Ticagrelol in Patients With STEMI

Conditions: Myocardial Infarction
NCT04255602

Recruiting

A Randomized Non-inferiority Study of Low-dose and Standard-dose Ticagrelor After Intervention for Acute Coronary Syndrome

Conditions: Acute Coronary Syndrome; Coronary Stent Implantation
NCT04250116

Not yet recruiting

Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents

Conditions: Atrial Fibrillation
NCT04240834

Not yet recruiting

Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention

Conditions: Acute Coronary Syndrome; Interventional Cardiology
NCT04237922

Active, not recruiting

Replication of the TRITON-TIMI Antiplatelet Trial in Healthcare Claims Data

Conditions: Antiplatelet
NCT04237935

Active, not recruiting

Replication of the PLATO Antiplatelet Trial in Healthcare Claims Data

Conditions: Antiplatelet
NCT04229264

Recruiting

Efficacy and Safety of Apixaban in Reducing Restenosis and Limb Loss in PAD Patients.

Conditions: Critical Limb Ischemia
NCT04206176

Completed

The Effects of loW Dose tIcagrelor on Platelet Function Testing in Patients With Stable Coronary arTery Disease

Conditions: Platelet Dysfunction Due to Drugs
NCT04174261

Completed

Ticagrelor in Remote Ischemic Preconditioning Study

Conditions: Periprocedural Myocardial Infarction
NCT04171687

Completed

Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers

Conditions: Healthy
NCT04165629

Recruiting

Platelet Reactivity in PAD Undergoing Percutaneous Angioplasty

Conditions: Peripheral Artery Disease; Critical Limb Ischemia; Claudication, Intermittent
NCT04142151

Recruiting

Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke

Conditions: Ischemic Stroke; Antiplatelet Effect
NCT04138641

Completed

Dutch Cangrelor Registry

Conditions: STEMI - ST Elevation Myocardial Infarction; NSTEMI - Non-ST Segment Elevation MI; Coronary Artery Disease
NCT04122170

Recruiting

Phase 2B Study to Evaluate the Efficacy of PB2452 in Reversal of Ticagrelor in Subjects Aged 50-80 Years

Conditions: Healthy
NCT04116931

Recruiting

Switch From Ticagrelor to Clopidogrel in ACS Patients After PCI

Conditions: Acute Coronary Syndrome (ACS)
NCT04100135

Not yet recruiting

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study

Conditions: Migraine; Patent Foramen Ovale
NCT04091074

Not yet recruiting

Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting

Conditions: Carotid Stenosis
NCT04088123

Not yet recruiting

Impact of Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy Subjects

Conditions: Thrombosis; Artery
NCT04088513

Recruiting

Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)

Conditions: G6PD Deficiency; Stroke
NCT04078737

Recruiting

Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II

Conditions: Stroke; Transient Ischemic Attack
NCT04069234

Withdrawn

Study in Diabetes Mellitus Patients Without Prior Myocardial Infarction or Stroke Undergoing Elective Percutaneous Coronary Intervention.

Conditions: Diabetes Mellitus; Microvascular Coronary Artery Disease
NCT04060914

Not yet recruiting

LOwer Maintenance Dose TICagrelor in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

Conditions: Antiplatelet Therapy; Coronary Artery Disease; Percutaneous Coronary Intervention
NCT04057300

Recruiting

Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes

Conditions: Acute Coronary Syndrome
NCT04023630

Not yet recruiting

DUAL Antithrombotic Therapy in Patients With AF and ACS

Conditions: Atrial Fibrillation; Acute Coronary Syndromes
NCT04014803

Not yet recruiting

Aspirin and a PoTent P2Y12 Inhibitor Versus Aspirin and Clopidogrel in Patients Undergoing PCI for Complex Lesion

Conditions: Coronary Artery Disease
NCT04006288

Recruiting

Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease

Conditions: Coronary Artery Disease
NCT04007055

Active, not recruiting

The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular Interventions

Conditions: Peripheral Artery Disease; Clopidogrel, Poor Metabolism of; Peripheral Vascular Disease; Artery Disease; Peripheral Arterial Occlusive Disease
NCT04005729

Recruiting

Cangrelor in Comatose Survivors of OHCA Undergoing Primary PCI

Conditions: Out-Of-Hospital Cardiac Arrest; Acute Coronary Syndrome
NCT04001374

Completed

Platelet Sub-study of the TWILIGHT Trial

Conditions: Coronary Artery Disease; Myocardial Infarction